Show simple item record

dc.contributor.authorUniversity of Maryland, Baltimore. Research Advisory Task Force (COVID-19)en_US
dc.date.accessioned2020-03-19T15:52:17Z
dc.date.available2020-03-19T15:52:17Z
dc.date.issued2020-03-18
dc.identifier.urihttp://hdl.handle.net/10713/12289
dc.descriptionGuidelines for UMB researchers regarding enrollment/continuation of research protocol based on level of risk. Includes Minimal Risk, Greater Than Minimal Risk (potential for direct benefit to research subject), Greater Than Minimal Risk (no potential for direct benefit to research subject), and Community Research (nursing home, senior centers and other community facilities). Created in response to the coronavirus pandemic.en_US
dc.language.isoen_USen_US
dc.subjectCoronavirus Disease 2019 (COVID-19)en_US
dc.subject.lcshUniversity of Maryland, Baltimoreen_US
dc.subject.lcshCOVID-19 (Disease)en_US
dc.subject.meshCOVID-19en_US
dc.titleFinal UMB policy based upon the committee report and recommendations: Clinical Researchen_US
dc.typeLetter/Memoen_US
refterms.dateFOA2020-03-19T15:52:18Z


Files in this item

Thumbnail
Name:
Clinical Research.3.18.20.pdf
Size:
321.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record